Skip to main navigation Skip to search Skip to main content

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

RUBY Investigators

Fingerprint

Dive into the research topics of 'Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science